Selective reduction of allelic variants

Details for Australian Patent Application No. 2011213562 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Bennett, C. Frank; Freier, Susan M.; Greenlee, Sarah; Swayze, Eric E

Agent Pizzeys

Pub. Number AU-A-2011213562

PCT Pub. Number WO2011/097643

Priority 61/302,469 08.02.10 US; 61/371,635 06.08.10 US

Filing date 8 February 2011

Wipo publication date 11 August 2011

International Classifications

C12N 15/11 Mutation or genetic engineering - DNA or RNA fragments

C07H 21/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

23 August 2012 PCT application entered the National Phase

  PCT publication WO2011/097643 Priority application(s): WO2011/097643

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011213563-Selective reduction of allelic variants

2011213559-Nucleic acid molecules encoding RANTES, and compositions comprising and methods of using the same